doxazosin has been researched along with MEA 2a in 2 studies
Doxazosin: A prazosin-related compound that is a selective alpha-1-adrenergic blocker.
doxazosin : A member of the class of quinazolines that is quinazoline substituted by an amino group at position 4, methoxy groups at positions 6 and 7 and a piperazin-1-yl group at position 2 which in turn is substituted by a 2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl group at position 4. An antihypertensive agent, it is used in the treatment of high blood pressure.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Iglesias, P | 1 |
Santacruz, E | 1 |
García-Sancho, P | 1 |
Marengo, AP | 1 |
Guerrero-Pérez, F | 1 |
Pian, H | 1 |
Fajardo, C | 1 |
Villabona, C | 1 |
Díez, JJ | 1 |
Scholten, A | 1 |
Vriens, MR | 1 |
Cromheecke, GJ | 1 |
Borel Rinkes, IH | 1 |
Valk, GD | 1 |
2 other studies available for doxazosin and MEA 2a
Article | Year |
---|---|
Pheochromocytoma: A three-decade clinical experience in a multicenter study.
Topics: 3-Iodobenzylguanidine; Adolescent; Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Adult; Age | 2021 |
Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients.
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-1 Receptor Antagon | 2011 |